The guidance provided by Novo Nordisk assumes that a reduction in compounded semaglutide in the second half of the year will benefit both Wegovy and Ozempic, two of its leading products.

Novo Nordisk ... versions of its Ozempic and Wegovy drugs, particularly in the U.S., a practice the U.S. Food & Drug Administration has allowed while supplies of Novo Nordisk’s treatments ...

The U.S. Food and Drug Administration had allowed companies to custom-make compounded versions of Novo Nordisk's GLP-1 drugs due to a shortage of Wegovy and Ozempic, but said in February that the ...

Q1 Wegovy sales rose 85% to DKK 17.36 billion; Ozempic up 18% to DKK 32.72 billion. Novo Nordisk's Q1 sales hit $10.89 billion, missing the $11.64 billion consensus estimate. Don’t miss this ...

Shares of Novo Nordisk jumped nearly 7% on Wednesday after ... to make legal copies of Novo's Wegovy and diabetes drug Ozempic under a drug shortage ruling by the FDA. The FDA declared that ...

Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, cut its annual sales forecast on Wednesday, citing a decline in its US market share.

Novo Nordisk is scheduled to report results for ... around the reasons for lack of demand in the U.S." --UBS models Ozempic sales of 31.88 billion kroner in the quarter, up from 27.81 billion ...

The US Food and Drug Administration seized fake Ozempic injections. This happened on April 9, 2025. Novo Nordisk warned about these fake drugs. Elon Musk mentioned using a similar drug.

Novo Nordisk NOVO.B-0.78%decrease; red down pointing triangle said the Food and Drug Administration accepted its submission of a new drug application for a Wegovy pill to treat obesity amid a ...

including drugmaker Novo Nordisk’s Ozempic and Wegovy. The findings may be an indicator that more patient education is necessary when it comes to taking the drugs. “We found that it’s very ...

Novo Nordisk ... loss and Ozempic for diabetes. As Reuters points out, more than 1 billion people around the world suffer from obesity and are potential consumers of Novo Nordisk's drugs (as ...